tenk.fyi

Insight Molecular Diagnostics Inc.

IMDXNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$1.9M

25.1% YoY

Net Income

-$60.7M

118.4% YoY

EPS

$-4.66

24.3% YoY

Cash

$8.6M

8.4% YoY

FY 2024 · As of 2024-12-31